Contemporary mortality differences between primary percutaneous coronary intervention and thrombolysis in ST-segment elevation myocardial infarction

Archives of Internal Medicine

Volumn 171, Issue 6, 2011, Pages 544-549

  Claeys, Marc J ^a   de Meester, Antoine ^b   Convens, Carl ^c   Dubois, Philippe ^d   Boland, Jean ^e   de Raedt, Herbert ^f   Vranckx, Pascal ^g   Coussement, Patrick ^h   Gevaert, Sofie ⁱ   Sinnaeve, Peter ^j   Evrard, Patrick ^k   Beauloye, Christophe ^l   Renard, Marc ^m   Vrints, Christiaan ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b Hospital de Jolimont   (Belgium)

^c ZiekenhuisNetwerk Antwerpen   (Belgium)

^d Centre Hospitalier Universitaire de Charleroi   (Belgium)

^e Centre Hospitalier Regional de La Citadelle   (Belgium)

^f OLV HOSPITAL   (Belgium)

^g VIRGA JESSE HOSPITAL   (Belgium)

^h AZ Sint Jan   (Belgium)

ⁱ GHENT UNIVERSITY HOSPITAL   (Belgium)

^j UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^k UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^l UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^m UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD CLOT LYSIS; CLINICAL ASSESSMENT; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REPERFUSION; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; ANGIOPLASTY, BALLOON, CORONARY; FEMALE; FIBRINOLYTIC AGENTS; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; REGISTRIES; REPERFUSION; RISK; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 79955132162     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2011.57     Document Type: Article

References (22)

1. Van de Werf F, Bax J, Betriu A, et al; ESC Committee for Practice Guidelines (CPG). Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2008;29(23):2909-2945.
2. Kushner FG, Hand M, Smith SC Jr, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines [published correction appears in J Am Coll Cardiol. 2010;55(6):612 and J Am Coll Cardiol. 2009;54(25):2464]. J Am Coll Cardiol. 2009;54(23):2205-2241.
3. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361(9351):13-20.
4. Dalby M, Bouzamondo A, Lechat P, Montalescot G. Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis. Circulation. 2003;108(15):1809-1814.
5. Sabatine MS, Cannon CP, Gibson CM, et al; CLARITY-TIMI 28 Investigators. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med. 2005;352(12):1179-1189.
6. Antman EM, Morrow DA, McCabe CH, et al; ExTRACT-TIMI 25 Investigators. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med. 2006;354(14):1477-1488.
7. Danchin N, Coste P, Ferrières J, et al; FAST-MI Investigators. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the French Registry on Acute ST-Elevation Myocardial Infarction (FAST-MI). Circulation. 2008;118(3):268-276.
8. Cantor WJ, Fitchett D, Borgundvaag B, et al; TRANSFER-AMI Trial Investigators Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med. 2009;360(26):2705-2718.
9. Bøhmer E, Hoffmann P, Abdelnoor M, Arnesen H, Halvorsen S. Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances: results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial infarction). J Am Coll Cardiol. 2010;55(2):102-110.
10. Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation: an Intravenous nPA for Treatment of Infarcting Myocardium Early II trial substudy. Circulation. 2000;102(17):2031-2037.
11. Morrow DA, Antman EM, Parsons L, et al. Application of the TIMI risk score for ST-elevation MI in the National Registry of Myocardial Infarction 3. JAMA. 2001;286(11):1356-1359.
12. Fernandez-Avilés F, Alonso JJ, Castro-Beiras A, et al; GRACIA (Grupo de Análisis de la Cardiopatía Isquémica Aguda) Group. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial. Lancet. 2004;364(9439):1045-1053.
13. Di Mario C, Dudek D, Piscione F, et al; CARESS-in-AMI (Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction) Investigators. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial. Lancet. 2008;371(9612):559-568.
14. Gibson CM, Pride YB, Frederick PD, et al. Trends in reperfusion strategies, doorto- needle and door-to-balloon times, and in-hospital mortality among patientswith ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006. Am Heart J. 2008;156(6):1035-1044.
15. Widimsky P, Wijns W, Fajadet J, et al; European Association for Percutaneous Cardiovascular Interventions. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J. 2010;31(8):943-957.
16. Thune JJ, Hoefsten DE, Lindholm MG, et al; Danish Multicenter Randomized Study on Fibrinolytic Therapy Versus Acute Coronary Angioplasty in Acute Myocardial Infarction (DANAMI)-2 Investigators. Simple risk stratification at admission to identify patients with reduced mortality from primary angioplasty. Circulation. 2005;112(13):2017-2021.
17. Pieper KS, Gore JM, FitzGerald G, et al; Global Registry of Acute Coronary Events (GRACE) Investigators. Validity of a risk-prediction tool for hospital mortality: the Global Registry of Acute Coronary Events. Am Heart J. 2009;157(6):1097-1105.
18. Kent DM, Ruthazer R, Griffith JL, et al. Comparison of mortality benefit of immediate thrombolytic therapy versus delayed primary angioplasty for acute myocardial infarction. Am J Cardiol. 2007;99(10):1384-1388.
19. Pinto DS, Kirtane AJ, Nallamothu BK, et al. Hospital delays in reperfusion for STelevation myocardial infarction: implications when selecting a reperfusion strategy. Circulation. 2006;114(19):2019-2025.
20. Gibson CM, Karha J, Murphy SA, et al; TIMI Study Group. Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis in Myocardial Infarction trials. J Am Coll Cardiol. 2003;42(1):7-16.
21. Zijlstra F, Hoorntje JCA, de Boer M-J, et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 1999;341(19):1413-1419.
22. Eagle KA, Nallamothu BK, Mehta RH, et al; Global Registry of Acute Coronary Events (GRACE) Investigators. Trends in acute reperfusion therapy for STsegment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. Eur Heart J. 2008;29(5):609-617.